Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Kansas › Overland Park
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Overland Park, KS keessatti
Qorannoo 11 Leukemia Myeloidii Hamaa f Overland Park fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Namoota walitti qabaa jiraSadarkaa 3
- US-Kansas City KS-KUMC, Fairway · Miili 3 fagaatti
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · Miili 3 fagaatti
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Namoota walitti qabaa jiraSadarkaa 1
- The University of Kansas Medical Center Research Institute, Fairway · Miili 3 fagaatti
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas, Fairway · Miili 3 fagaatti
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Namoota walitti qabaa jiraSadarkaa 2
- University of Kansas Cancer Center, Fairway · Miili 3 fagaatti
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas Cancer Center, Fairway · Miili 3 fagaatti
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Seattle, WAQorannoo 41
- Baldwin Park, CAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 31
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
Qorannoo biroo Overland Park keessatti
- Kansara Qara'a Non-Small CellQorannoo 16
- Dhibee QaraQorannoo 11
- Saree OljooQorannoo 10
- Fibrillation AtrialQorannoo 8
- Kansarii ColorectalQorannoo 8
- ObesityQorannoo 7
- Kansarii PancreasQorannoo 7
- Kansarii ProstateQorannoo 7
- MelanomaQorannoo 6
- Baayyee UlfaataaQorannoo 6
- Kansarii OvariiQorannoo 6
- Saree (Gosoota Hunda)Qorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.